Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients. A Hellenic Cooperative Oncology Group Study.
暂无分享，去创建一个
N. Pavlidis | G. Fountzilas | D. Skarlos | C. Kolotas | N. Zamboglou | N. Tsavaris | G. Klouvas | N. Mylonakis | S. Vassilaros | P. Makrantonakis | P. Kosmidis | A. Polichronis | K. Gennatas | S. Tsiliakos | T. Giannakakis | C. Semoglou | C. Konstantaras | E. Fahantidis | D. Toussis | K. Katsohis | D. Hainoglou